Monash IVF Group (ASX: MVF) Webcast Replay
Monash IVF Group (ASX: MVF) a global IVF pioneer and leader in fertility services with a $378 million market cap.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Michael Knaap, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 27th October 2021 at 12pm (AEDT).
FEATURED SPEAKER
Michael Knaap
Chief Executive Officer - Monash IVF Group (ASX: MVF)
Monash IVF Group is the pioneer of IVF and a global leader in assisted reproductive services, genetic testing and ultrasound services. The company was the first to achieve successful IVF and has since been a driving force in the development of assisted reproductive technologies and tertiary level prenatal diagnostics. Monash IVF Group currently has a market share of 21% and operates more than 40 fertility and ultrasound clinics across Australia. Showing a 61.5% increase in net profits and 26.3% revenue growth in FY21, the company is poised to grow considerably with the increasing demand for fertility services.